CNY 7.87
(10.07%)
Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
---|---|---|---|---|---|---|
Operating Cash Flow | 288.69 Million | -284.25 Million | 386.05 Million | 134.21 Million | 91.91 Million | 151.82 Million |
Net Income | 131.22 Million | 118.68 Million | 156.62 Million | 181.05 Million | 161.95 Million | 203.92 Million |
Depreciation & Amortization | 154.33 Million | 147.63 Million | 156.13 Million | 131.61 Million | 99.15 Million | 64.83 Million |
Deferred income taxes | 18.66 Million | -4.98 Million | 7.36 Million | 15.53 Million | 14.51 Million | -11.35 Million |
Stock-based compensation | - | - | -7.36 Million | -15.53 Million | 10.31 Million | 32.32 Million |
Change in working capital | -57.67 Million | -664.83 Million | 63.97 Million | -165.57 Million | -164.06 Million | -180.46 Million |
Other non-cash items | 59.6 Million | 114.25 Million | 9.31 Million | -12.88 Million | -29.95 Million | 63.53 Million |
Investing Cash Flow | -82.6 Million | -198.46 Million | -156.63 Million | -198.71 Million | 175.32 Million | -846.78 Million |
Investments in PPE | -84.36 Million | -199.8 Million | -158.05 Million | -202.82 Million | -247.69 Million | -334.27 Million |
Acquisitions | 1.76 Million | 884.97 Thousand | 581.39 Thousand | 205.39 Million | 25.51 Million | 335.49 Million |
Investment purchases | - | -50 Million | -751 Million | -671.86 Million | -1.02 Billion | -1.27 Billion |
Sales/Maturities of investments | - | 50.46 Million | 751.83 Million | 673.39 Million | 1.41 Billion | 761.68 Million |
Other Investing Activities | 1.76 Million | 0.15 | 0.90 | -202.82 Million | 1 Million | -334.27 Million |
Financing Cash Flow | 166.64 Million | 423.8 Million | -123.07 Million | 4.29 Million | -87.04 Million | 494.67 Million |
Debt repayment | -238.7 Million | -25.5 Million | -56.01 Million | -55.99 Million | -12.22 Million | -1.59 Million |
Dividends payments | -35.87 Million | -47.6 Million | -53.35 Million | -48.72 Million | -61.28 Million | -93.02 Million |
Common Stock Repurchased | - | - | -49.67 Million | -2.76 Million | -13.65 Million | - |
Common Stock Issuance | - | - | 49.67 Million | -53.23 Million | 13.65 Million | - |
Other Financing Activities | -10 Million | 511.4 Million | -11.69 Million | 165.22 Million | -13.19 Million | 587.7 Million |
Accounts receivables | 112.38 Million | -174.64 Million | -466.28 Million | -457 Million | -210 Million | -100.58 Million |
Accounts payables | -180.49 Million | 15.53 Million | 682.14 Million | 480.9 Million | 146.64 Million | 47.45 Million |
Inventory | -8.22 Million | -500.74 Million | -155.56 Million | -202.71 Million | -115.22 Million | -115.98 Million |
Other working capital | -161.83 Million | -4.98 Million | 3.68 Million | 13.24 Million | 14.51 Million | -64.48 Million |
Cash at beginning of period | 274.09 Million | 333 Million | 226.66 Million | 286.85 Million | 106.65 Million | 306.93 Million |
Cash at end of period | 646.82 Million | 274.09 Million | 333 Million | 226.66 Million | 286.85 Million | 106.65 Million |
Capital Expenditure | -84.36 Million | -199.8 Million | -158.05 Million | -202.82 Million | -247.69 Million | -334.27 Million |
Effect of forex changes on cash | - | - | 0.14 | 1.00 | -0.34 | 1.18 |
Net cash flow / Change in cash | 372.73 Million | -58.91 Million | 106.34 Million | -60.19 Million | 180.2 Million | -200.27 Million |
Free Cash Flow | 204.32 Million | -484.06 Million | 228 Million | -68.6 Million | -155.78 Million | -182.44 Million |
Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | 20.21 Million | 56.04 Million | -104.69 Million | 77.4 Million | 131.22 Million | 17.93 Million |
Depreciation & Amortization | - | 46.1 Million | 46.1 Million | 154.33 Million | 154.33 Million | -74.6 Million |
Deferred income taxes | - | - | - | - | 18.66 Million | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | - | -125.02 Million | - | 104.16 Million | -57.67 Million | -79.92 Million |
Other non-cash items | 192.4 Million | -89.13 Million | -497.84 Thousand | 142.46 Million | 59.6 Million | 245.57 Million |
Investing Cash Flow | -4.86 Million | -3.74 Million | -16.17 Million | -28.61 Million | -82.6 Million | -38.99 Million |
Investments in PPE | -4.89 Million | -3.91 Million | -16.99 Million | -29.17 Million | -84.36 Million | -39 Million |
Acquisitions | 28.03 Thousand | 170.19 Thousand | 634.19 Thousand | 560.97 Thousand | 1.76 Million | 12 Thousand |
Investment purchases | - | - | -100 Million | - | - | - |
Sales/Maturities of investments | - | - | 100.19 Million | - | - | - |
Other Investing Activities | 28.03 Thousand | 170.19 Thousand | 827.86 Thousand | 560.98 Thousand | 1.76 Million | 12 Thousand |
Financing Cash Flow | -113.78 Million | 32.17 Million | -13.46 Million | -20.51 Million | 166.64 Million | -150.45 Million |
Debt repayment | -105.8 Million | -82.2 Million | -5 Million | -10.3 Million | -238.7 Million | -105 Million |
Dividends payments | -6.66 Million | -46.59 Million | -6.91 Million | -35.87 Million | -35.87 Million | -43.08 Million |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | - | - | - | - | - | - |
Other Financing Activities | -1.32 Million | -45.04 Million | -1.54 Million | -3.06 Million | -10 Million | -2.37 Million |
Accounts receivables | - | 44.52 Million | - | 112.38 Million | 112.38 Million | -336.77 Million |
Accounts payables | - | - | - | - | -180.49 Million | - |
Inventory | - | -169.54 Million | - | -8.22 Million | -8.22 Million | 256.85 Million |
Other working capital | - | - | - | - | - | - |
Cash at beginning of period | 461.24 Million | 608.09 Million | 646.82 Million | 217.59 Million | 274.09 Million | 298.05 Million |
Cash at end of period | 555.2 Million | 555.08 Million | 512 Million | 646.82 Million | 646.82 Million | 217.59 Million |
Capital Expenditure | -4.89 Million | -3.91 Million | -16.99 Million | -29.17 Million | -84.36 Million | -39 Million |
Effect of forex changes on cash | - | - | - | - | - | 0.05 |
Net cash flow / Change in cash | 93.96 Million | -53.01 Million | -134.82 Million | 429.23 Million | 372.73 Million | -80.45 Million |
Free Cash Flow | 207.72 Million | -83.1 Million | -122.19 Million | 449.18 Million | 204.32 Million | 69.97 Million |
HBIO
BSBR
002150
BAC-PM
PRN
7360